CN Stock MarketDetailed Quotes

600223 Lushang Freda Pharmaceutical

Watchlist
  • 8.49
  • -0.12-1.39%
Market Closed Dec 26 15:00 CST
8.63BMarket Cap36.44P/E (TTM)

About Lushang Freda Pharmaceutical Company

The company is a listed company controlled by Shandong Commercial Group Co., Ltd., and Lushang Development will adhere to the “healthy life service provider” position, focus on the three major business chains of “healthy city construction ecological chain, biomedical product chain, and health management service chain”, create “full coverage of healthy life, full improvement of health quality, and full optimization of health experience” brand services for customers, and strive to grow into a comprehensive healthy life service group integrating science, industry and trade, industry, education and research. The company's main business covers business segments such as cosmetics, pharmaceuticals, raw materials and additives. In addition, it also involves property management and other fields. Corporate honors: Heze City's Top 20 Real Estate Development Enterprises with Comprehensive Strength, AAA Enterprise Credit Rating Enterprise, Double Top 10 Enterprise, “Golden Round Table Award” of the 12th China Listed Company Board of Directors, Comprehensive Credit Green Card Enterprise, etc.

Company Profile

Short Name-A福瑞达
Symbol-A600223
Company NameLushang Freda Pharmaceutical Co.,Ltd.
Listing DateJan 13, 2000
Issue Price6.80
Shares Offered110.00M share(s)
FoundedApr 21, 1993
Listed ExchangeSH Stock Exchange
Legal Representativeqingwen jia
General Managerchunmingdai gao
Secretaryhongyang zhang
Accounting FirmShanghui Accounting Firm (Special General Partnership)
Securities Representativeweiyu dai
Legal CounselGuo Hao Law Firm (Jinan)
Employees100
Phone0531-66699999
Office AddressNo. 888 Xinluo Street, High-tech Zone, Jinan City, Shandong Province
Zip Code250101
Registered AddressBoshan Economic Development Zone, Zibo City, Shandong Province
Fax0531-66697128
Emaillsfrd600223@163.com
Business License370000018020768
BusinessGeneral projects: medical research and experimental development; cosmetic retail; cosmetics wholesale; bio-based material manufacturing; bio-based material technology research and development; biochemical product technology research and development; technical services, technology development, technical consultation, technology exchange, technology transfer, technology promotion; health consulting services (excluding diagnosis and treatment services); nursing services; nursing institution services (excluding medical services); investment activities with own capital. (In addition to projects subject to approval according to law, independent business activities are carried out according to law with a business license) Licensed projects: pharmaceutical production; pharmaceutical wholesale; drug internet information service; drug contract production; drug import and export; pharmaceutical retail; cosmetics production. (Projects requiring approval according to law can only carry out business activities after approval by relevant departments. Specific business projects are subject to the relevant department's approval documents or licenses)

Company Executives

  • Name
  • Position
  • Salary
  • qingwen jia
  • Chairman, Directors, Strategy and ESG Committee Convener
  • 1.16M
  • ming zhou
  • Directors, Nomination Committee Members
  • --
  • yuhai su
  • Independent Directors, Remuneration and Assessment Committee Convener, Nomination Committee Convener, Strategy and ESG Committee Member, Audit Committee Member
  • 100.00K
  • desheng zhu
  • Independent Directors, Audit Committee Convener, Nomination Committee Members, Member of the Remuneration and Assessment Committee
  • 100.00K
  • zhuo wang
  • Outside Directors, Audit Committee Member, Member of the Remuneration and Assessment Committee, Strategy and ESG Committee Member
  • --
  • hongyang zhang
  • Board Secretary, Deputy General Manager
  • 95.80K
  • weiyu dai
  • Securities Affairs Representative
  • --
  • yuanzhong lv
  • Chairman of the Supervisory Board, Shareholder Supervisors
  • --
  • ruiping cha
  • Shareholder Supervisors
  • --
  • qianqian dou
  • Deputy General Manager
  • 95.80K
  • deqiang zheng
  • Deputy General Manager
  • 95.80K
  • chunming gao
  • Deputy General Manager, Acting General Manager
  • 95.80K
  • baiqiang xu
  • Chief Financial Officer
  • 95.80K
  • xiaomin cheng
  • Chief Development Officer
  • 1.28M
  • ze wang
  • Employee Supervisors
  • 322.70K